Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis.

Miyashita, Hirotaka

Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis. [electronic resource] - Breast cancer research and treatment Jun 2020 - 279-289 p. digital

Publication Type: Journal Article; Meta-Analysis; Review

1573-7217

10.1007/s10549-020-05640-3 doi


Aromatase Inhibitors--adverse effects
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Breast Neoplasms--drug therapy
Female
Humans
Osteoporosis--chemically induced
Prognosis